This leadership position is accountable for delivering overall commercial strategy of the 
PCS oncology assets, by partnering closely with R&D, in-line commercial in US, 
international region, and countries, and other key stakeholders to plan for the 
commercialization of assets in the Oncology pipeline, thereby delivering successful global 
product launches within the portfolio in oncology.
Responsibilities:
• Develop, champion and communicate vision and overall compelling strategy to all 
related stakeholder groups gaining commitment and support to guide portfolio 
prioritization, asset strategies and BD investments.
• Understand market, key segment value drivers, growth opportunities, target product 
profiles, product positioning and revenue potential for multiple clinical-stage
assets/indications within the franchise to drive winning portfolio value proposition 
plans and strong P&L investment thesis
• (Co)-lead tumor disease are strategy teams for development of multiple assets 
within same tumor, when applicable – with enterprise and portfolio mindset
• Defines and drives strategic value creation across lifecycle together with R&D and 
commercial cross-functional partners, integrating diverse internal and external 
perspectives
• Partner with Global Medical Affairs, Pharma Development, and Commercial Crossfunctional leaders to develop scientific platforms and drive data generation to 
satisfy Global and Area requirements for target product labels and target product 
claims. 
• Identify new value generation for the franchise to unlock further opportunity. Drive 
innovative and novel ways to accelerate commercialization, and maximize value for 
patients and the company for the franchise
• Drive prioritization of key leverage points in the treatment process and develop 
behavioral objectives for each stakeholder group to define commercial strategy for 
the assets and for the entire franchise
• Effective and transparent risk, opportunity and issue management at strategic and 
operational levels across the franchise
• Initiate geo-strategy and indication prioritization within the franchise in partnership 
with R&D, Commercial cross-functional leaders, and Affiliates on formulating 
optimal reimbursement and access strategies to fully realize value of multiple 
assets.
• Exhibit clear and courageous leadership behavior and implements optimal program 
structures where appropriate to drive timely and effective decision making
• Broaden AbbVie’s Oncology network and presence by building scientific, academic, 
KOL, payer, and patient advocacy relationships.